Adjust Font Increase Font Decrease Font
  • Email
  • Print
  • RSS Feed

Media Releases

WASHINGTON, D.C. (February 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “PhRMA is currently reviewing the final regulation of the Physician Payments Sunshine Act and looks forward to seeing how CMS addressed key concerns that were previously raised. PhRMA remains committed to the principles of the Sunshine Act and continues to believe that careful implementation is essential to ensuring that Sunshine fulfills its objective of usable, transparent, and understandable sharing of information.” About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies...

Latest Releases

6/26/2012
"Today’s Senate passage of S. 3187, the Food and Drug Administration (FDA) Safety and Innovation Act of 2012, is the culmination of a multi-year effort on the part of biopharmaceutical companies, FDA, Congress, and stakeholders that featured unprecedented collaboration, public input, and bipartisanship."
6/18/2012
PhRMA applauds today’s introduction of the Food and Drug Administration Safety and Innovation Act of 2012 (S. 3187), and thanks Congress, the Food and Drug Administration (FDA), and other stakeholders who have participated in the months and years of work to negotiate and pass this important legislation.